This report aims to provide a comprehensive presentation of the global market for Connected Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Connected Drug Delivery Devices. This report contains market size and forecasts of Connected Drug Delivery Devices in global, including the following market information:
- Global Connected Drug Delivery Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Connected Drug Delivery Devices Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Connected Drug Delivery Devices companies in 2022 (%)
The global Connected Drug Delivery Devices market was valued at US$ 157.4 million in 2022 and is projected to reach US$ 384 million by 2029, at a CAGR of 13.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Inhalation Devices Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Connected Drug Delivery Devices include Bayer AG, Propeller Health, West Pharmaceutical Services, Inc, 3M Company, OPKO Health, Sagentia (Science Group), Cohero Health, Care TRx and CeQur SA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Connected Drug Delivery Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Connected Drug Delivery Devices Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Connected Drug Delivery Devices Market Segment Percentages, by Type, 2022 (%)
- Inhalation Devices
- Injectable Devices
Global Connected Drug Delivery Devices Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Connected Drug Delivery Devices Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics
- Home Care
Global Connected Drug Delivery Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Connected Drug Delivery Devices Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Connected Drug Delivery Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Connected Drug Delivery Devices revenues share in global market, 2022 (%)
- Key companies Connected Drug Delivery Devices sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Connected Drug Delivery Devices sales share in global market, 2022 (%)
key players include:
- Bayer AG
- Propeller Health
- West Pharmaceutical Services, Inc
- 3M Company
- OPKO Health
- Sagentia (Science Group)
- Cohero Health
- Care TRx
- CeQur SA
- Biocorp Production SA
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Connected Drug Delivery Devices, market overview.
- Chapter 2: Global Connected Drug Delivery Devices market size in revenue and volume.
- Chapter 3: Detailed analysis of Connected Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Connected Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Connected Drug Delivery Devices capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
